Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM
Cancer Care in Older Adults and Special Population
The clinical impact of the Choosing Wisely project
Why tumour markers are not recommended as screening tests
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC
Applying the syndemic framework to cancer research for effective cancer control in LMICs
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients
IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours
Higher BMI may be linked with worse survival among SBS88 positive CRC patients
MatchMiner: An open-source AI precision medicine trial matching platform